Nomura/Instinet maintains Chugai Pharmaceutical at Buy, PT $5000.00

  • Investing.com
Nomura/Instinet maintains Chugai Pharmaceutical at Buy, PT $5000.00

A Nomura/Instinet analyst maintained Chugai Pharmaceutical (TYO: 4519) at Buy and a price target of $5000.00.

Prior to this rating, Chugai Pharmaceutical had 9 buy ratings, 5 hold ratings, and 0 sell ratings.

For consensus analyst estimates and price targets on Chugai Pharmaceutical, click here. For more news on Chugai Pharmaceutical, click here.

Chugai Pharmaceutical's stock price closed at $3.0. They are down -99.91% in the last month and down -12.6% in the last 12 months.

According to Investing Pro, Chugai Pharmaceutical's fair value is $3.9K, an upside of 12.8%. Chugai Pharmaceutical's fair value comes with a low degree of uncertainty, according to InvestingPro.

Check out Chugai Pharmaceutical's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles